- Citations, last 5 years
- 680
- Works, last 5 years
- 184
- h-index
- 83
- Scientists listed
- 13
- Grants since 2016
- 1 402
Grants received
2022–2027 · research · R01
Programmable benchtop bioreactors for scalable eco-evolutionary dynamics of the human microbiome
Ahmad Samir Khalil · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · R01
Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain
Irving J. Bigio · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Tailoring of cellular mechanical microenvironments to rescue age-related impairments in bone regeneration
Elise F Morgan · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · R01
Using Machine Learning to Optimize User Engagement and Clinical Response to Digital Mental Health Interventions
Todd J. Farchione · Charles River Associates · funded by National Institutes of Health
2022–2025 · fellowship · F32
Sensory and Control Mechanisms of Temporal Attention
Michael Lewis Epstein · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Linking motor cortex activity and movement in the mouse orofacial system.
Michael Nicholas Economo · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R01
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
Daniel G Dillon · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R35
Probing co-transcriptional gene regulatory logics in human transcriptomes
Ana Fiszbein · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R25
Mystery of the Crooked Cell 2.0: CityLab's Next Generation SocioscientificApproach to Gene Editing
Donald A Derosa · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
2/2-CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Michael W. Otto · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Tailoring of cellular mechanical microenvironments to rescue age-related impairments in bone regeneration
Elise F Morgan · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
Daniel G Dillon · Charles River Associates · funded by National Institutes of Health
2022–2027 · career development · K23
Reducing psychological barriers to PrEP persistence among pregnant and postpartum women in Cape Town, South Africa
Amelia M. Stanton · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · R01
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
Michael Birnbaum · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Alcohol and "Heat of the Moment" Sexual Decision Making among MSM: Identifying Mechanisms of Sexual Risk and Promoting Behavior Change Through Brief Intervention
Stephen A Maisto · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R01
CRCNS: Neural Representations of Time Across Scales in Natural and Artificial Networks
Marc W Howard · Charles River Associates · funded by National Institutes of Health
2022–2025 · fellowship · F31
Simultaneous Optical Voltage Imaging and fMRI in Behaving Mice
Patrick Doran · Charles River Associates · funded by National Institutes of Health
2022–2027 · training · T32
Training Program in Quantitative Biology & Physiology (QBP)
John A. White · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R01
Xenobiotic-responsive hepatic long non-coding RNAs
David J Waxman · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · RF1
High-throughput mapping of synaptic connectivity between transcriptomically defined cell types
Michael Nicholas Economo · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R21
Sub-millimeter precision wireless neuromodulation using a microwave split ring resonator
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2022–2024 · cooperative agreement · U01
Efficient Two-Photon Voltage Imaging of Neuronal Populations at Behavioral Timescales
Jerry L Chen · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Linking Motor Cortex Activity and Movement in the Mouse Orofacial System
Michael Nicholas Economo · Charles River Associates · funded by National Institutes of Health
2022–2025 · fellowship · F31
How Does Attention and Arousal Interact to Modulate Vision?
Jasmine Pan · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R25
Mystery of the Crooked Cell 2.0: CityLab's Next Generation SocioscientificApproach to Gene Editing
Donald A Derosa · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Functional heterogeneity of vasoactive intestinal peptide-expressing interneurons in the anterior cingulate cortex
Alberto Cruz-Martin · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R01
CRCNS: Neural Representations of Time Across Scales in Natural and Artificial Networks
Marc W Howard · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R21
R21: A novel antibody-drug conjugate for treatment of squamous cell lung carcinoma
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
Daniel G Dillon · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · R01
Using Machine Learning to Optimize User Engagement and Clinical Response to Digital Mental Health Interventions
Todd J. Farchione · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
2/2-CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Michael W. Otto · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R21
Sub-millimeter precision wireless neuromodulation using a microwave split ring resonator
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
A Bio-inspired Latent TGF-beta Conjugated Scaffold for Patient-specific Cartilage Regeneration
Michael B Albro · Charles River Associates · funded by National Institutes of Health
2022–2023 · fellowship · F31
Engineering CAR T Cells to Establish Stable Mixed Chimerism in Allogeneic Transplantation
Menna Yamany Siddiqui · Charles River Associates · funded by National Institutes of Health
2022–2024 · research · R21
R21: A novel antibody-drug conjugate for treatment of squamous cell lung carcinoma
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
Daniel G Dillon · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Linking Motor Cortex Activity and Movement in the Mouse Orofacial System
Michael Nicholas Economo · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health